Israel Englander Astrazeneca PLC Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $31.6 Million - $36.1 Million	412,000 Added 108.11%	793,100 $61.8 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $14.2 Million - $17.2 Million	212,400 Added 125.9%	381,100 $29.7 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $10.3 Million - $11.7 Million	168,700 New	168,700 $11.4 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $24.9 Million - $27 Million	-355,800 Reduced 48.47%	378,200 $27.1 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $41.9 Million - $47.5 Million	663,300 Added 938.19%	734,000 $50.9 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $6.86 Million - $8.91 Million	-126,500 Reduced 64.15%	70,700 $4.79 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $8.1 Million - $20.7 Million	-152,800 Reduced 43.66%	197,200 $10.8 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.